Language: BG BG
← Back to results
Recruiting Not applicable NCT07549126

Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1

No applicable phase (e.g. observational)
Conditions: Opioid Use Disorder Clinical Decision Support

Sponsor: Yale University

trial.available_in: БГ
Overview
This study is stage 2, round 1 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
Description
Investigators will use a Multiphase Optimization Strategy (MOST) framework study with preparation, optimization, and confirmatory phases. In the current stage, optimization phase, stage 2 investigators will conduct serial rapid-cycle randomized testing to inform iterative refinement of the CDS interface and workflow to minimize user errors, task disruption, and abandonment through identification of specific targets for improvement via application of novel CDS outcome measures with the goal of improving CDS usability. Five rounds of A-B testing are planned. The more successful condition will be tested in the subsequent round against a novel test condition. In the first round we will test the placement of the nurse prompt to complete COWS randomizing encounters to place the prompt under either required or optional documentation. Future rounds will be planned, with arms and interventions added, as the project progresses in order to build on insights gained in each round. The last study phase, the evaluation phase will consist of a randomized trial of the optimized package compared to the original EMBED and the evaluation phase in which investigators will compare the efficacy of the optimized, multicomponent CDS package to the original EMBED CDS on ED-initiation of buprenorphine rates in patients with OUD in a randomized trial. \*EMBED is a user centered, clinician facing clinical decision support system integrated into the electronic health record workflow to facilitate initiating buprenorphine in the emergency department by: diagnosing opioid use disorder with a checklist based on the diagnostic criteria of the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, fifth edition), assessing the severity of withdrawal with the Clinical Opioid Withdrawal Scale (COWS), motivating patients to accept treatment with a scripted brief negotiation interview, and automating the electronic health record workflow, including clinical and after visit documentation, order entry, prescribing, and referral for ongoing treatment in the community This study does not have open enrollment.
Who can participate
Inclusion Criteria: * Emergency department patient * 18 years of age or older * Moderate to severe opioid use disorder Exclusion Criteria: * Under 18 years of age * Pregnant * Currently receiving medication for opioid use disorder
Interventions
Nurse prompt to complete COWS under required documentation
OTHER
Refined EMBED CDS
OTHER
Locations 3
United States (3)
Yale New Haven Shoreline Medical Center
Guilford , Connecticut
Yale New Haven Hospital- St. Raphael
New Haven , Connecticut
Yale New Haven Hospital
New Haven , Connecticut
Technical details
Status
Recruiting
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
06.04.2026
Completion date
01.06.2027
Registry ID
NCT07549126
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.